Repaglinide Tablet
Product Images NDC 57237-159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 57237-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Repaglinide Fig1)

FDA Label Image

Package Label-principal Display Panel (0.5 mg (100 Tablet Bottle))

Package Label-principal Display Panel (0.5 mg (100 Tablet Bottle))
Rising® NDC57237-157-01 is a medication containing Repaglinide that comes in tablet form with 0.5 mg strength. The tablets are to be stored at room temperature, protected from moisture and out of reach of children. The usual dosage and prescribing information can be found in the package insert. The medication is distributed by Rising Health, LLC and made in India. No other information is provided.*
FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablet Bottle))

Package Label-principal Display Panel (1 mg (100 Tablet Bottle))
Rising NDc57237-158-01 is a package of Repaglinide Tablets, USP with 1 mg strength, containing 100 tablets. It is recommended to store them in a cool and dry place away from children. While the package does not disclose many other details, the recommended dosage information can be found in the package insert. The package is distributed by Made Rising Health, LLC based in Saddle Brook, NJ.*
FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))
Rising® NDC57237-159-01 offers tablets of Repaglinide, USP 2 mg each, in a quantity of 100 tablets. It is suggested to refer to the package insert for complete prescribing information and to store the product at a controlled room temperature between 20 to 25°C (68 to 77°F). Rising Health, LLC manufactures the item in India, and it is distributed from Saddle Brook, NJ 07663. It is crucial to keep the tablets packed in a tightly sealed container with a child-resistant cap and to prevent exposure to moisture while keeping them away from children. No more information is available.*
FDA Label Image

Chemical Structure (Repaglinide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.